[5-fluoro-2-(piperidin-1-yl)pyridin-4-yl]boronic acid

Catalog No. :
ACDKBX530
CAS No. :
2225176-46-3
Molecular Formula :
C10H14BFN2O2
Molecular Weight :
224.04

IUPAC Name:(5-fluoro-2-(piperidin-1-yl)pyridin-4-yl)boronic acid

[5-fluoro-2-(piperidin-1-yl)pyridin-4-yl]boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$195.00Login to see priceInquiryInquiry
250mg95%$312.00Login to see priceInquiryInquiry
1g95%$701.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[5-fluoro-2-(piperidin-1-yl)pyridin-4-yl]boronic acid
IUPAC Name(5-fluoro-2-(piperidin-1-yl)pyridin-4-yl)boronic acid
MDL No.MFCD28054646
Molecular FormulaC10H14BFN2O2
Molecular Weight224.04
SMILESOB(O)C1=CC(=NC=C1F)N1CCCCC1
InChI KeyXZQCYZSEZIGPAI-UHFFFAOYSA-N
Synonym5-Fluoro-2-(piperidino)pyridine-4-boronic acid;[5-fluoro-2-(piperidin-1-yl)pyridin-4-yl]boronic acid;Boronic acid, B-[5-fluoro-2-(1-piperidinyl)-4-pyridinyl]-
CAS No.2225176-46-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDKBX530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRFDM628 route compound structure diagram
    ACRFDM628951677-47-7 In Stock
  4. Then
  5. ACDKBX530 route product structure diagram
    ACDKBX5302225176-46-3
Inquiry

2. ACDKBX530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEMQ791 route compound structure diagram
    ACIEMQ7911263375-23-0 In Stock
  4. Then
  5. ACDKBX530 route product structure diagram
    ACDKBX5302225176-46-3
Inquiry

Comments (0)